The Turkish Validity-Reliability Study of the European Heart Failure Self-Care Behavior Scale-Caregivers Version

January 19, 2024 updated by: İbrahim Caner Di̇ki̇ci̇, Harran University

The Turkish Validity-Reliability Study of the European Heart Failure Self-Care Behavior Scale-Caregivers Version (AKYÖDÖ-BV)

The aim of this study was to evaluate the translation, cross-cultural fit, and psychometric properties of the European Heart Failure Self-Care Behavior Questionnaire for Caregivers.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This research will be of descriptive type. The population of the study will be heart failure patients who applied to the University Hospital Cardiology clinic and polyclinic. The sample of the study will consist of patients who meet the research criteria and agree to participate in the study. The data collection tools of the study are the patient questionnaire (17 questions), the European Heart Failure Self-Care Behavior Scale for Caregivers (9 questions) and the Caregiver Contribution Scale in Heart Failure Self-Care, which was conducted by the researchers by scanning the literature.

English Turkish translations will be made before starting the research. Afterwards, expert opinion will be taken for the suitability of the scale items. Then, the Turkish scale items will be translated back into English and the linguist's opinion will be taken that the scale can be applied. Language and content validity will be done for the scale form. The scale items will be translated into Turkish and expert opinions will be taken. Then, the Turkish scale items will be translated back into English and the linguist's opinion will be taken that the scale can be applied. Language validity and content validity will be done in the study. Explanatory Factor Analysis will be applied for the validity of the questionnaire. Kaiser Meyer Olkin(KMO) Test, which measures the adequacy of sample size as antecedent tests, and Bartlett's Test For Sphericity will be used to test sphericity. Factor Analysis Principal Component Analysis Method will be applied.

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Türki̇ye
      • Şanlıurfa, Türki̇ye, Turkey, 63000
        • Harran University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients with Heart Failure

Description

Inclusion Criteria:

  • be over 18
  • To be a caregiver for patients with heart failure for at least 1 year.
  • Volunteer to participate in the research.

Exclusion Criteria:

  • Having communication problems and mental problems.
  • be under the age of 18.
  • Receiving hemodialysis treatment for less than 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
European Heart Failure Self-Care Behavior Scale for Caregivers
Time Frame: Baseline
Using a five-point Likert scale, patients report the extent to which they agree with the statements corresponding to the 9-item self-care behavior (for example, weighing oneself every day), with responses ranging from "totally agree" to "disagree".
Baseline
Scale of Caregiver Contribution in Heart Failure Self-Care
Time Frame: Baseline
"Caregiver contribution scale in heart failure self-care", which consists of 22 items, consists of 3 separate scales.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Harran University

Investigators

  • Study Director: İbrahim C Di̇ki̇ci̇, MSc, Harran Üniversitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 12, 2022

Primary Completion (Actual)

September 10, 2022

Study Completion (Actual)

September 10, 2023

Study Registration Dates

First Submitted

June 11, 2022

First Submitted That Met QC Criteria

June 11, 2022

First Posted (Actual)

June 15, 2022

Study Record Updates

Last Update Posted (Actual)

January 22, 2024

Last Update Submitted That Met QC Criteria

January 19, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 268347889

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Heart Failure Group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe